|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期2012-01-01 |
A Phase-III, Randomized, Open Label, Parallel Group, Active Controlled, Multicentre, Non-Inferiority Clinical Study to Evaluate the Immunogenicity and Safety Of Varivax® [Varicella vaccine (Live Attenuated, Lyophilized I.P) of VHB Life Sciences Limited] Compared to a Marketed Varicella Vaccine in Healthy Paediatric Subjects aged between 1 to 12 years.
100 项与 VHB Life Sciences Ltd. 相关的临床结果
0 项与 VHB Life Sciences Ltd. 相关的专利(医药)
100 项与 VHB Life Sciences Ltd. 相关的药物交易
100 项与 VHB Life Sciences Ltd. 相关的转化医学